Tuli tuomiota vähän selailtua ja siellä on tuo kahden pelaajan viestinvaihto mielenkiintoinen sivuhaara. Pelaaja 2 jää mysteeriksi, puhutaan kuitenkin kansainvälisen tason pelaajasta.
Tuomiossa ei mun mielestä oteta sitten noihin viesteihin ainakaan isommin kantaa, ja kakku tullut ikään kuin törkeästä huolimattomuudesta ja ITIA toteaa, että pelaajan olisi tullut huomata jos nyt lähtemässä väärää annosta suoneen.
Purcellin selitykset tuolla on luokkaa, että ei tiennyt et klinikka on antanut yli satasen annoksia vaikka se meriselitys nyt näillä faktoilla tuoksuu kilometrien päähän.
During its investigation, the ITIA recovered data from the mobile phone of another professional tennis player (Player 2) that included a number of WhatsApp messages exchanged between the Player and Player 2, while both players were travelling internationally.
On 16 December 2023, the two players exchanged messages relating to a “hydration session” at a medical clinic (Clinic) and at approximately 15:45, the Player sent messages to Player 2 confirming that he had received an infusion.
The two players exchanged a number of further messages that day concerning the infusion. These messages indicate that: (i) the Player requested the Clinic staff not to keep receipts relating to his infusion; (ii) the Player discussed ways in which he could justify receiving infusions, including feigning illness; and (iii) the Player subsequently researched whether or not the infusion was prohibited under the WADA Code (specifically, whether it was the ingredient itself or the water that was relevant to the limit of 100 mL within 12 hours). The relevance of these messages is addressed below in Section III.A.
Later exchanges between the two players, as well as a picture sent by Player 2 to a member of staff at the Clinic, establish that the Player also received an infusion at the Clinic on 20 December 2023.
Turning then to the applicable Period of Ineligibility and specifically to the question of intent, the Prohibited Method in question is a Specified Method, which, pursuant to the comment to Article 4.2.2 of the Code means that it is not “considered less important or less dangerous than other doping [methods]” but is “more likely to have been consumed or used by an Athlete for a purpose other than the enhancement of sport performance”.
The facts and evidence in these proceedings demonstrate a significant degree of fault and negligence on the part of the Player. The Player is a very high level tennis player who has received anti-doping education over a number of years and is, by his own account, well aware of the high standard expected of him when it comes to meeting his anti-doping obligations. Irrespective of
whether the Player requested an infusion of 100 mL or not, by his own admission he never sought to verify whether his request had been understood, including by taking the extremely simple step of looking at the IV bag containing the infusion.
The Player’s fault in this case is therefore substantial and does not meet the requirements for a reduction of his Period of Ineligibility on the basis of No Significant Fault or Negligence.
Tuolta voi lukea koko tuomion: